Adherence Monitoring and E-Health: How Clinicians and Researchers Can Use Technology to Promote Inhaler Adherence for Asthma

Journal of Allergy and Clinical Immunology: In Practice

Volumn 1, Issue 5, 2013, Pages 446-454

  Chan, Amy Hai Yan ^a   Reddel, Helen Kathryn ^b   Apter, Andrea ^c   Eakin, Michelle ^d   Riekert, Kristin ^d   Foster, Juliet Michelle ^b  

^a THE UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adherence; Asthma; Electronic medication monitoring; Materials testing

Indexed keywords

BUDESONIDE; CORTICOSTEROID; STEROID;

ACCURACY; ARTICLE; ASTHMA; CLINICAL PRACTICE; COMPUTER PROGRAM; DRUG MONITORING; ELECTRONIC MONITORING DEVICE; FEEDBACK SYSTEM; HUMAN; INHALER; MEDICAL DEVICE; MEDICAL RESEARCH; MEDICAL TECHNOLOGY; MEDICATION COMPLIANCE; METERED DOSE INHALER; NEBULIZER; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELIABILITY; REMINDER SYSTEM; SELF CARE; PERSONNEL; PHYSICIAN; TELEMEDICINE; UTILIZATION;

ASTHMA; HUMANS; MEDICATION ADHERENCE; NEBULIZERS AND VAPORIZERS; PHYSICIANS; RESEARCH PERSONNEL; TELEMEDICINE;

EID: 84883443977     PISSN: 22132198     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaip.2013.06.015     Document Type: Article

References (66)

1. Foster JM, Lavoie KL, Boulet L. Treatment adherence and psychosocial factors in severe asthma. In: Chung KF, Bel E, Wenzel S, editors. Difficult-to-treat Asthma. Germany: European Respiratory Society Monograph; 2011:28-49.
2. Otsuki M., Eakin M.N., Rand C.S., Butz A.M., Hsu V.D., Zuckerman I.H., et al. Medication adherence feedback to improve asthma outcomes among inner-city children: a randomized controlled trial. JPediatr 2009, 124:1513-1521.
3. Williams L.K., Pladevall M., Xi H., Peterson E.L., Joseph C., Lafata J.E., et al. Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. JAllergy Clin Immunol 2004, 114:1288-1293.
4. Williams L.K., Peterson E.L., Wells K., Ahmedani B.K., Kumar R., Burchard E.G., et al. Quantifying the proportion of severe asthma exacerbations attributable to inhaled corticosteroid nonadherence. JAllergy Clin Immunol 2011, 128:1185-1191.
5. Suissa S., Ernst P., Benayoun S., Baltzan M., Cai B. Low-dose inhaled corticosteroids and the prevention of death from asthma. NEngl J Med 2000, 343:332-336.
6. Cutler D.M., Everett W. Thinking outside the pillbox: medication adherence as a priority for health care reform. NEngl J Med 2010, 362:1553-1555.
7. National Research Council, Institute of Medicine. Initial National Priorities for Comparative Effectiveness Research 2009, The National Academies Press, Washington, DC.
8. Osterberg L., Blaschke T. Adherence to medications. NEngl J Med 2005, 353:487-497.
9. Rand C.S., Wise R.A., Nides M., Simmons M.S., Bleecker E.R., Kusek J.W., et al. Metered-dose inhaler adherence in a clinical trial. Am Rev Respir Dis 1992, 146:1559-1564.
10. Nides M., Tashkin D.P., Simmons M.S., Wise R., Li V.C., Rand C.S. Improving inhaler adherence in a clinical trial through the use of the nebulizer chronolog. Chest 1993, 104:501-507.
11. Bender B., Wamboldt F.S., O'Connor S.L., Rand C., Szefler S., Milgrom H., et al. Measurement of children's asthma medication adherence by self report, mother report, canister weight, and Doser CT. Ann Allergy Asthma Immunol 2000, 85:416-421.
12. Simmons M.S., Nides M.A., Rand C.S., Wise R.A., Tashkin D.P. Unpredictability of deception in compliance with physician-prescribed bronchodilator inhaler use in a clinical trial. Chest 2000, 118:290-295.
13. Peterson A.M., Nau D.P., Cramer J.A., Benner J., Gwadry-Sridhar F., Nichol M. Achecklist for medication compliance and persistence studies using retrospective databases. Value Health 2007, 10:3-12.
14. Walders N., Kopel S.J., Koinis-Mitchell D., McQuaid E.L. Patterns of quick-relief and long-term controller medication use in pediatric asthma. JPediatr 2005, 146:177-182.
15. Rand C.S., Sevick M.A. Ethics in adherence promotion and monitoring. Control Clin Trials 2000, 21:S241-S247.
16. Nikander K., Turpeinen M., Pelkonen A.S., Bengtsson T., Selroos O., Haahtela T. True adherence with the Turbuhaler in young children with asthma. Arch Dis Child 2011, 96:168-173.
17. Foster J.M.F., Smith L., Usherwood T., Sawyer S.M., Rand C.S., Reddel H.K. The reliability and patient acceptability of the Smart Track device: a new electronic monitor and reminder device for metered dose inhalers. JAsthma 2012, 49:657-662.
18. Lacasse Y., Archibald H., Ernst P., Boulet L.P. Patterns and determinants of compliance with inhaled steroids in adults with asthma. Can Respir J 2005, 12:211-217.
19. Patel M., Pilcher J., Pritchard A., Perrin K., Travers J., Shaw D., et al. Efficacy and safety of maintenance and reliever combination budesonide-formoterol inhaler in patients with asthma at risk of severe exacerbations: a randomised controlled trial. Lancet 2013, I:32-42.
20. Papi A., Canonica G.W., Maestrelli P., Paggiaro P., Olivieri D., Pozzi E., et al. Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma. NEngl J Med 2007, 356:2040-2052.
21. Calhoun W.J., Ameredes B.T., King T.S., Icitovic N., Bleecker E.R., Castro M., et al. Comparison of physician-, biomarker-, and symptom-based strategies for adjustment of inhaled corticosteroid therapy in adults with asthma: the basalt randomized controlled trial. JAMA 2012, 308:987-997.
22. Bender B.G. Advancing the science of adherence measurement: implications for the clinician. JAllergy Clin Immunol: In Practice 2013, 1:92-93.
23. Onyirimba F., Apter A., Reisine S., Litt M., McCusker C., Connors M., et al. Direct clinician-to-patient feedback discussion of inhaled steroid use: its effect on adherence. Ann Allergy Asthma Immunol 2003, 90:411-415.
24. Foster J.M., Smith L., Bosnic-Anticevich S.Z., Usherwood T., Sawyer S.M., Rand C.S., et al. Identifying patient-specific beliefs and behaviours for conversations about adherence in asthma. Intern Med J 2012, 42:e136-e144.
25. Sawicki G.S., Strunk R.C., Schuemann B., Annett R., Weiss S., Fuhlbrigge A.L. Patterns of inhaled corticosteroid use and asthma control in the Childhood Asthma Management Program Continuation Study. Ann Allergy Asthma Immunol 2010, 104:30-35.
26. Jentzsch N.S., Camargos P., Sarinho E.S.C., Bousquet J. Adherence rate to beclomethasone dipropionate and the level of asthma control. Respir Med 2012, 106:338-343.
27. Rand C., Bilderback A., Schiller K., Edelman J.M., Hustad C.M., Zeiger R.S., et al. Adherence with montelukast or fluticasone in a long-term clinical trial: results from the mild asthma montelukast versus inhaled corticosteroid trial. JAllergy Clin Immunol 2007, 119:916-923.
28. Kim C., Feldman H.I., Joffe M., Tenhave T., Boston R.C., Apter A.J. The influences of earlier adherence and symptoms on current symptoms. JAllergy Clin Immunol 2005, 115:810-814.
29. Borrelli B., Riekert K.A., Weinstein A., Rathier L. Brief motivational interviewing as a clinical strategy to promote asthma medication adherence. JAllergy Clin Immunol 2007, 120:1023-1030.
30. McNamara P.S., McCormack P., McDonald A.J., Heaf L., Southern K.W. Open adherence monitoring using routine data download from an adaptive aerosol delivery nebuliser in children with cystic fibrosis. JCyst Fibros 2009, 8:258-263.
31. Simmons M.S., Nides M.A., Rand C.S., Wise R.A., Tashkin D.P. Trends in compliance with bronchodilator use between follow-up visits in a clinical trial. Chest 1996, 109:963-968.
32. Burgess S.W., Sly P.D., Devadason S.G. Providing feedback on adherence increases use of preventive medication by asthmatic children. JAsthma 2010, 47:198-201.
33. Bartlett S.J., Lukk P., Butz A., Lampros-Klein F., Rand C.S. Enhancing medication adherence among inner-city children with asthma: results from pilot studies. JAsthma 2002, 39:47-54.
34. Apter A., Wang X., Bogen D., Rand C., McElligott S., Polsky D., et al. Problem solving to improve adherence and asthma outcomes in urban adults with moderate or severe asthma: a randomized controlled trial. JAllergy Clin Immunol 2011, 128:516-523.
35. Vervloet M., Linn A.J., van Weert J.C.M., de Bakker D.H., Bouvy M.L., van Dijk L. The effectiveness of interventions using electronic reminders to improve adherence to chronic medication: a systematic review of the literature. JAm Med Inform Assoc 2012, 19:696-704.
36. Charles T., Quinn D., Weatherall M., Aldington S., Beasley R., Holt S. An audiovisual reminder function improves adherence with inhaled corticosteroid therapy in asthma. JAllergy Clin Immunol 2007, 119:811-816.
37. Black P., Garratt E., Noonan L., Arandjus C., Salmon B., Sutherland G. An inhaler with ringtones improves compliance with inhaled steroids in childhood asthma. Am J Respir Crit Care Med 2008, 117(suppl):A615.
38. PriceWaterhouseCoopers' Health Research Institute. Healthcare unwired: new business models delivering care anywhere. 2010. Available from: Accessed August 1, 2013. http://www.pwc.com/us/en/health-industries/publications/healthcare-unwired.jhtm.
39. McLean S., Protti D., Sheikh A. Telehealthcare for long term conditions. BMJ 2011, 342. d120.
40. Taylor D.R., Bateman E.D., Boulet L.P., Boushey H.A., Busse W.W., Casale T.B., et al. Anew perspective on concepts of asthma severity and control. Eur Respir J 2008, 32:545-554.
41. Spahn J., Sheth K., Yeh W.-S., Stempel D.A., Stanford R.H. Dispensing of fluticasone propionate/salmeterol combination in the summer and asthma-related outcomes in the fall. JAllergy Clin Immunol 2009, 124:1197-1203.
42. Weinstein A.G. Asthma adherence management for the clinician. JAllergy Clin Immunol: In Practice 2013, 1:123-128.
43. Pew Research Center. The Social Life of Health Information. 2011. Available from: Accessed August 17, 2012. http://pewinternet.org/Reports/2011/Social-Life-of-Health-Info.aspx.
44. Sovani M.P., Whale C.I., Oborne J., Cooper S., Mortimer K., Ekström T., et al. Poor adherence with inhaled corticosteroids for asthma: can using a single inhaler containing budesonide and formoterol help?. Br J Gen Pract 2008, 58:37-43.
45. Rohan J., Drotar D., McNally K., Schluchter M., Riekert K., Vavrek P., et al. Adherence to pediatric asthma treatment in economically disadvantaged African-American children and adolescents: an application of growth curve analysis. JPediatr Psychol 2010, 35:394-404.
46. Celano M.P., Linzer J.F., Demi A., Bakeman R., Smith C.O., Croft S., et al. Treatment adherence among low-income, African-American children with persistent asthma. JAsthma 2010, 47:317-322.
47. Riekert K.A., Rand C.S. Electronic monitoring of adherence: when is high-tech best?. JClin Psych Med Settings 2002, 9:25-34.
48. Herzer M., Ramey C., Rohan J., Cortina S. Incorporating electronic monitoring feedback into clinical care: a novel and promising adherence promotion approach. Clin Child Psychol Psychiatry 2012, 17:505-518.
49. Zolnierek K.B., Dimatteo M.R. Physician communication and patient adherence to treatment: a meta-analysis. Med Care 2009, 47:826-834.
50. Aldridge D. Project red and asthmapolis. Comput Inform Nurs 2011, 29:542-543.
51. Weinstein A.G. Should patients with persistent severe asthma be monitored for medication adherence?. Ann Allergy Asthma Immunol 2005, 94:251-257.
52. Julius S.M., Sherman J.M., Hendeles L. Accuracy of three electronic monitors for metered-dose inhalers. Chest 2002, 121:871-876.
53. Ingerski L.M., Hente E.A., Modi A.C., Hommel K.A. Electronic measurement of medication adherence in pediatric chronic illness: a review of measures. JPediatr 2011, 159:528-534.
54. Simmons M.S., Nides M., Kleerup E.C., Chapman K.R., Milgrom H., Rand C., et al. Validation of the Doser, a new device for monitoring metered-dose inhaler use. JAllergy Clin Immunol 1998, 102:409-413.
55. O'Connor S.L., Bender B.G., Gavin-Devitt L.A., Wamboldt M.Z., Milgrom H., Szefler S., et al. Measuring adherence with the Doser CT in children with asthma. JAsthma 2004, 41:663-670.
56. Burgess S.W., Wilson S.S.I., Cooper D.M., Sly P.D., Devadason S.G. In vitro evaluation of an asthma dosing device: the smart-inhaler. Respir Med 2006, 100:841-845.
57. Turtona J.A., Glasgow N.J., Brannan J.D. Feasibility and acceptability of using bronchial hyperresponsiveness to manage asthma in primary care: a pilot study. Prim Care Respir J 2012, 21:28-34.
58. Patel M., Pilcher J., Chan A., Perrin K., Black P., Beasley R. Six-month in vitro validation of a metered-dose inhaler electronic monitoring device: implications for asthma clinical trial use. JAllergy Clin Immunol 2012, 130:1420-1422.
59. Patel M., Pilcher J., Travers J., Perrin K., Shaw D., Black P., et al. Use of metered-dose inhaler electronic monitoring in a real-world asthma randomized controlled trial. JAllergy Clin Immunol: In Practice 2013, 1:83-91.
60. Naimi D.R., Freedman T.G., Ginsburg K.R., Bogen D., Rand C.S., Apter A.J. Adolescents and asthma: why bother with our meds?. JAllergy Clin Immunol 2009, 123:1335-1341.
61. Bogen D., Apter A.J. Adherence logger for a dry powder inhaler: a new device for medical adherence research. JAllergy Clin Immunol 2004, 114:863-868.
62. Trinity College Dublin. Neural Engineering Group. Trinity Centre for Bioengineering: Telemedicine. Available from: Accessed June 5, 2012. http://www.mee.tcd.ie/neuraleng/Research/Telemedicine.
63. Daniels T., Goodacre L., Sutton C., Pollard K., Conway S., Peckham D. Accurate assessment of adherence: self-report and clinican report vs electronic monitoring of nebulizers. Chest 2011, 140:425-432.
64. Denyer J. Adherence monitoring in drug delivery. Expert Opin Drug Deliv 2010, 7:1127-1131.
65. Nikander K., Arheden L., Denyer J., Cobos N. Parents' adherence with nebulizer treatment of their children when using an adaptive aerosol delivery (AAD) system. JAerosol Med 2003, 16:273-281.
66. Brand P., Schulte M., Wencker M., Herpich C.H., Klein G., Hanna K., et al. Lung deposition of inhaled a1-proteinase inhibitor in cystic fibrosis and α-1-antitrypsin deficiency. Eur Respir J 2009, 34:354-360.